Eximore is a brand that is revolutionizing the delivery and efficacy of eye medication. Our novel drug delivery system is designed to reduce the risk and improve patient outcomes for a range of ophthalmic conditions. Through our innovative punctal plug, we significantly increase patient compliance and optimize consistent dosing, thus reducing the risk of vision loss.

Unlike traditional eye drops, our integrated Pack & Release drug delivery system offers accurate dosing and sustained release of active medication to the surface of the eye. This system eliminates the need for preservatives and allows for mono or combo therapy in a single plug. The plug is inserted in a non-invasive procedure at the doctor's office, ensuring ease and convenience for patients.

Our technology is based on nano-particle technology, which allows for the molding of the drug into the plug itself. This allows for sustained release and targeted treatment of chronic conditions like glaucoma and dry eye syndrome. To learn more about our lead programs, such as treating glaucoma and ocular hypertension, or our second program focused on treating dry eye syndrome, visit our website.

Meet our team of scientific, medical, engineering, and business leaders behind this revolutionary technology. Contact us to request additional information and discover how Eximore is transforming ophthalmic drug delivery to improve patient outcomes